Состояние щитовидной железы у девочек-подростков с ожирением

REFERENSES

Peterkova V.A., Bezlepkina O.B., Bolotova N.V. et al. Clinical

guidelines “Obesity in children”. Problems of Endocrinology.

;67(5):67–83. (In Russian). DOI: 10.14341/probl12802.

NCD Risk Factor Collaboration (NCD-RisC). Worldwide

trends in underweight and obesity from 1990 to

: a pooled analysis of 3663 population-representative

studies with 222 million children, adolescents,

and adults. Lancet. 2024;403(10431):1027–1050.

DOI: 10.1016/S0140-6736(23)02750-2.

Gritsinskaya V.L., Novikova V.P., Khavkin A.I. On the

epidemiology of obesity in children and adolescents

(a systematic review and meta-analysis of scientifi c

publications over a 15-year period). Issues of Practical

Pediatrics. 2022;17(2):126–135. (In Russian).

DOI: 10.20953/ 1817-7646-2022-2-126-135.

Multidisciplinary problems of obesity in children.

V.P. Novikova, M.M. Gurova, eds. Saint Petersburg: Spets-

Lit; 2018. (In Russian).

Nikitina I.L. Obesity in children and adolescents: theproblem,

solutions. Review of Russian and international recommendations.

Lechashchii vrach. 2018;(1):31–34. (In

Russian).

Alieva N.A. Peculiarities of endocrine status of adolescent

girls with obesity of various genesis. Bulletin of the Volgograd

State Medical University. 2007;1(21):26–29. (In Russian).

Firsova L.A., Shogiradze L.D., Evdokimova N.V. et al.

Нormonal and cytokine status in adolescent girls with

obesity. University Therapeutic Journal. 2022;4(S):137.

Golubev N.A., Ogryzko E.V., Shelepova E.A., Zalevskaya

O.V. Morbidity of children by diseases of the

endocrine system, itania’s diseases substance exchange

within the national project of “Health” of the

Russian Federation. Current problems of health care

and medical statistics. 2019;(3):358–371. (In Russian).

DOI: 10.24411/2312-2935-2019-10072.

Urmanova Yu.M., Azimova Sh.Sh., Rikhsieva N.T. Frequency

and structure of thyroid diseases in children

and adolescents according to appeals data. Mìžnarodnij

endokrinologìčnij žurnal. 2018;14(2):163–167. (In Russian).

DOI: 10.22141/2224-0721.14.2.2018.130562.

Ogryzko E.V., Shelepova E.A., Kuznetsova V.P. Dynamics

of thyroid disease incidence among children aged

–17 years in the Russian Federation. Modern problems

of health care and medical statistics. 2020;(3):341–356.

DOI: 10.24411/2312-2935-2020-00076.

Sanabria A., Kowalski L.P., Shah J.P. et al. Growing incidence

of thyroid carcinoma in recent years: Factors underlying

overdiagnosis. Head Neck. 2018;40(4):855–866.

DOI: 10.1002/hed.25029.

Dzhumagaziev A.A., Bezrukova D.A., Shilina N.A.,

Otto N.Yu., Sosinovskaya E.V., Filipchuk A.V. Genetic

and epigenetic risk factors for the development of

simple obesity in children: a literature review. Pediatric

Pharmacology. 2024;21(6):510–515. (In Russian).

DOI: 10.15690/pf.v21i6.2828.

Kiseleva A.V., Meshkov A.N., Ershova A.I. et al. Genetics

of obesity: current state of the problem. Preventive

Medicine. 2021;24(12):89–96. (In Russian).

DOI: 10.17116/profmed20212412189.

Kovtun O.P., Ustyuzhanina M.A. Molecular genetic basis

for the formation of obesity and related diseases in

children. Medical Science and Education of the Urals.

;19(1):48–54. (In Russian).

Mahmoud R., Kimonis V., Butler M.G. Genetics of

obesity in humans: a clinical review. Int J Mol Sci.

;23(19):11005. DOI: 10.3390/ijms231911005.

Battram T., Yousefi P., Crawford G. et al. The

EWAS Catalog: a database of epigenome-wide association

studies. Wellcome Open Res. 2022;7:41.

DOI: 10.12688/wellcomeopenres.17598.2.

Evdokimova N.V., Novikova V.P., Nakhimov T.A. et al. The

role of gene polymorphisms (AGT: c. 174C>T and AGT:

c. 235T>C) in children with obesity and cardiometabolic

disorders. Medical Council. 2024;18(19):116–124. (In

Russian). DOI: 10.21518/ms2024-387.

Evdokimova N.V., Shogiradze L.D., Pokhlebkina

A.A. et al. Genetic determinants of obesity in

adolescent girls. Russian Bulletin of Perinato logy

and Pediatrics. 2024:69(2):65–71. (In Russian).

DOI: 10.21508/1027-4065-2024-69-2-65-71.

Persani L., Rodien P., Moran C., Visser W.E., GroenewegS.,

Peeters R., Refetoff S., Gurnell M., Beck-Peccoz P., Chatterjee

K. 2024 European Thyroid Association Guidelines

on diagnosis and management of genetic disorders of

thyroid hormone transport, metabolism and action. Eur

Thyroid J. 2024;13(4):e240125. DOI: 10.1530/ETJ-24-0125.

Rosalie B.T.M. Sterenborg, Inga Steinbrenner, Yong Li

et al. Multi-trait analysis characterizes the genetics of

thyroid function and identifi es causal associations with

clinical implications. Nat Commun. 2024;15(1):888.

DOI: 10.1038/s41467-024-44701-9.

Vargas-Uricoechea H. Molecular Mechanisms in Autoimmune

Thyroid Disease. Cells. 2023;12(6):918.

DOI: 10.3390/cells12060918.

Amelyanovich M.D., Mosse I.B. Molecular genetic markers

of the risk of developing endocrine pathology. Molecular

and Applied Genetics. 2019;27:97–107. (In Russian).

EDN: CIMAFT.

Kucher A.N. FTO gene and diseases: the importance of

genetic polymorphism, epigenetic modifi cations and

environmental factors. Genetics. 2020;56(9):985–1005.

(In Russian). DOI: 10.31857/S0016675820090131.

Ji F.H., Fu X.H., Li G.Q., He Q., Qiu X.G. FTO Prevents

Thyroid Cancer Progression by SLC7A11

m6A Methylation in a Ferroptosis-Dependent Manner.

Front Endocrinol (Lausanne). 2022;13:857765.

DOI: 10.3389/fendo.2022.857765.

Fateeva A.A., Martirosyan N.S., Petunina N.A. Immunogenetic

features of thyroid pathology in combination with

metabolic syndrome. Medical Council. 2018;(4):116–119.

(In Russian). DOI: 10.21518/2079-701X-2018-4-116-119.

Deng M., Deng Y., Tang Z., Nie W., Lu Y., Wang X.,

WangZ., Kong Y. The mechanism of ranunculus ternatus

thunb. against esophageal squamous cell carcinoma

based on network pharmacology and experimental

verifi cation. Comb Chem High Throughput Screen. 2025.

DOI: 10.2174/0113862073376779250410054456.

Zakharova S.M., Savelieva L.V., Fadeeva M.I. Obesity and

hypothyroidism. Obesity and Metabolism. 2013;10(2):54–

(In Russian). DOI: 10.14341/2071-8713-4826.

Magomedova I.M., Kamalov K.G., Atayev M.G., Arslanbekova

A.Ch. Hypothyroidism and its role in the development

of carbohydrate and fat metabolism disorders

(li terature review). Environmental Medicine. 2019:2(1):9–

(In Russian). DOI: 10.34662/EM.2019.2.1.9-15.

Fontenelle L.C., Feitosa M.M., Severo J.S., Freitas T.E., Morais

J.B., Torres-Leal F.L., Henriques G.S., do Nascimento

Marreiro D. Thyroid function in human obesity: underlying

mechanisms. Horm Metab Res. 2016;48(12):787–794.

DOI: 10.1055/s-0042-121421.

Grandone A., Santoro N., Coppola F., Calabrò P., Perrone

L., Del Giudice E.M. Thyroid function derangement

and childhood obesity: an Italian experience. BMC Endocr

Disord. 2010;10:8. DOI: 10.1186/1472-6823-10-8.

Gurina O.P., Dementyeva E.A., Blinov A.E., Varlamova

O.N. Thyroid status in children suffering from obesity.

In the collection. In: VIII April readings in memory of

ProfessorM.V. Pikkel. Proceedings of the interregional

scientifi c and practical conference dedicated to the

memory of Professor M.V. Pikkel. 2020:40–43. (In Russian).

Biondi B. Subclinical hypothyroidism in patients with obesity

and metabolic syndrome: a narrative review. Nutrients.

;16(1):87. DOI: 10.3390/nu16010087.

Cheserek M.J., Wu G., Shen L., Shi Y. and Le G. Evaluation

of the relationship between subclinical hypothyroidism

and metabolic syndrome components among workers.

Int J Occup Med Environ Health. 2014;27:175–187.

DOI: 10.2478/s13382-014-0240-5.

Kota S.K., Meher L.K., Krishna S., Modi K. Hypothyroidism

in metabolic syndrome. Indian J Endocrinol

Metab. 2012;16(Suppl 2):332–333.

DOI: 10.4103/2230-8210.104079.

Feng X., Jiang Y., Meltzer P., Yen P.M. Thyroid hormone

regulation of hepatic genes in vivo detected

by complementary DNA microar ray. Mol Endocrinol.

;14(7):947–955. DOI: 10.1210/mend.14.7.0470.

Smirnov V.V., Ushakov A.I. Timely diagnosis

and treatment of hypothyroidism is the basis for

healthy mental and physical development of children.

Lechashchii vrach. 2020;1:10–16 (In Russian).

DOI: 10.26295/OS.2019.77.67.002.

Shvarts V. Adipose tissue infl ammation. Part 1. Morphological

and functional manifestations. Probl Endokrinol

(Mosk). 2009;55(4):44–49. (In Russian).

DOI: org/10.14341/probl200955444-49.

Sánchez B.T., Godoy S.J., García B.H., Barja Y.S. Niveles

de hormonas tiroideas en niños obesos [Thyroid function

in obese children]. Rev Chil Pediatr. 2014;85(3):288–297.

(In Spanish). DOI: 10.4067/S0370-41062014000300004.

Krause A.J., Cines B., Pogrebniak E., Sherafat-

Kazemzadeh R., Demidowich A.P., Galescu O.A.,

BradyS.M., Reynolds J.C., Hubbard V.S., Yanovski J.A.

Associations between adiposity and indicators of thyroid

status in children and adolescents. Pediatr Obes.

;11(6):551–558. DOI: 10.1111/ijpo.12112.

Khavkin A.I., Kolosova A.D., Novikova V.P. Biological role

and clinical signifi cance of leptin in pediatrics. Issues

of Practical Pediatrics. 2020;15(4):69–74. (In Russian).

DOI: 10.20953/1817-7646-2020-4-69-74.

Dornbush S., Aeddula N.R. Physiology, Leptin. 2023 Apr

In: StatPearls [Internet]. Treasure Island (FL): Stat-

Pearls Publishing; 2025 Jan.

Sucharda P. Obesity and thyroid gland. Cas Lek Cesk.

;161(5):194–197.

Pena-Leon V., Perez-Lois R., Villalon M., Prida E., Muñoz-

Moreno D., Fernø J., Quiñones M., Al-Massadi O., Seoane

L.M. Novel mechanisms involved in leptin sensitization

in obesity. Biochem Pharmacol. 2024;223:116129.

DOI: 10.1016/j.bcp.2024.116129.

Fatahi S., Fotros D., Sohouli M.H., Vahidshahi K., Rohani

P., Guimarães N.S. Meal replacements on obesity

and leptin: a systematic review and meta-analysis.

Rev Endocr Metab Disord. 2025;26(1):55–80.

DOI: 10.1007/s11154-024-09918-5.

Smetnik V.P. Sex hormones and adipose tissue. Obesity

and metabolism. 2007;3:17-22. (In Russian).

Ryazantseva E.M. Leptin and the female reproductive system.

Journal of obstetrics and wo men’s disea ses. 2012;61(5):

–103. (In Russian). DOI: 10.17816/JOWD61596-103.

Soydan L., Eren Ozturk H., Onal Z.E., Nuhoglu C. Associations

of thyroid volume and function with childhood obesity. Acta Endocrinol (Buchar). 2019;5(1):123–128.

DOI: 10.4183/aeb.2019.123.

Intestinal microbiota as a regulator of human organs

and systems. V.P. Novikova, M.M. Gurova, A.I. Khavkin,

ed. Moscow: GEOTAR-Media; 2024. (In Russian).

DOI 10.33029/9704-8174-5-I.

Cani P.D., Van Hul M. Gut microbiota in overweight

and obesity: crosstalk with adipose tissue. Nat

Rev Gastroenterol Hepatol. 2024;21(3):164–183.

DOI: 10.1038/s41575-023-00867-z.

Angelini G., Russo S., Mingrone G. Incretin hormones,

obesity and gut microbiota. Peptides. 2024;178:171216.

DOI: 10.1016/j.peptides.2024.171216.

Azari H., George M., Albracht-Schulte K. Gut MicrobiotamicroRNA

interactions and obesity pathophysiology: a

systematic review of integrated studies. Int J Mol Sci.

;25(23):12836. DOI: 10.3390/ijms252312836.

Evdokimova N.V., Pokhlebkina A.A., Petrenko Yu.V.

et al. Features of the intestinal microbiota in adolescents

with obesity. Actual problems of abdominal

pathology in child ren: Proceedings of the XXX Anniversary

Congress of Pediatric Gastroenterologists of

Russia and the CIS Countries. Moscow, March 14–16,

Moscow: Medpraktika-M; 2023: 166–168. (In

Russian).

Evdokimova N.V., Shogiradze L.D., Pokhlebkina A.A.

et al. Microbiota of the small intestine in adolescent

girls suffering from obesity. Experimental and clinical

gastroenterology. 2023;7(215):34–41. (In Russian).

DOI: 10.31146/1682-8658-ecg-215-7-34-41.

Stramazzo I., Capriello S., Filardo S., Centanni M., Virili

C. Microbiota and thyroid disease: an updated systematic

review. Adv Exp Med Biol. 2023;1370:125–144.

DOI: 10.1007/5584_2023_770.

Legakis I., Chrousos G.P., Chatzipanagiotou S. Thyroid

diseases and intestinal microbiome. Horm Metab Res.

;55(12):813–818. DOI: 10.1055/a-2190-3847.

Jiang W., Lu G., Gao D., Lv Z., Li D. The relationships between

the gut microbiota and its metabolites with thyroid

diseases. Front Endocrinol (Lausanne). 2022;13:943408.

DOI: 10.3389/fendo.2022.943408.

Zemskova E.A., Strukov E.L., Melnikova I.Yu., Novikova

V.P., Antonov P.V. Excessive growth of Eubacterium

lentum in the parietal intestinal microfl ora as a risk factor

for the development of thyroiditis in children. Bulletin

of the North-West State Medical University named after

I.I. Mechnikov. 2012;4(4):73–77. (In Russian).

Tabasi M., Eybpoosh S., Heravi F.S., Siadat S.D., Mousavian

G., Elyasinia F., Soroush A., Bouzari S. Gut microbiota

and serum biomarker analyses in obese patients diagnosed

with diabetes and hypothyroid disorder. Metabolic

Syndrome and Related Disorders. 2021;19(3):144–151.

DOI: 10.1089/met.2020.0119.

Wang Y., Dong X., Fu C., Su M., Jiang F., Xu D., Li R.,

QianJ., Wang N., Chen Y., Jiang Q. Thyroid stimulating

hormone (tsh) is associated with general and abdominal

obesity: a cohort study in school-aged girls during puberty

in East China. Front Endocrinol (Lausanne). 2020;11:620.

DOI: 10.3389/fendo.2020.00620.

Benvenga S., Di Bari F., Granese R., Borrielli I., GiorgianniG.,

Grasso L., Le Donne M., Vita R., Antonelli A. Circulating thyrotropin

is upregulated by estradiol. J Clin Transl Endocrinol.

;11:11–17. DOI: 10.1016/j.jcte.2018.02.002.

Tereshchenko I.V., Krivoshchekova O.Yu. State of

the hypothalamic-pituitary-thyroid system in patients

with pubertal-juvenile dyspituitarism. Problems

of Endocrinology. 2000;46(5):18–21. (In Russian).

DOI: 10.14341/probl11871.

Nader N.S., Bahn R.S., Johnson M.D., Weaver A.L., Singh R.,

Kumar S. Relationships between thyroid function and lipid

status or insulin resistance in a pediatric population. Thyroid.

;20(12):1333–1339. DOI: 10.1089/thy.2010.0180.

Mustafayeva I.R. Features of changes in hormonal levels

in adolescent girls with obesity during puberty. Russian

Bulletin of Obstetrician-Gynecologist. 2023;23(4):5–8. (In

Russian). DOI: 10.17116/rosakush2023230415.

ЛИТЕРАТУРА

Петеркова В.А., Безлепкина О.Б., Болотова Н.В.

и др. Клинические рекомендации. Ожирение у де-

тей. Проблемы эндокринологии. 2021;67(5):67–83.

DOI: 10.14341/probl12802.

NCD Risk Factor Collaboration (NCD-RisC). Worldwide

trends in underweight and obesity from 1990 to

: a pooled analysis of 3663 population-representative

stu dies with 222 million children, adolescents,

and adults. Lancet. 2024;403(10431):1027–1050.

DOI: 10.1016/S0140-6736(23)02750-2.

Грицинская В.Л., Новикова В.П., Хавкин А.И. К во-

просу об эпидемиологии ожирения у детей и под-

ростков (систематический обзор и мета-анализ

научных публикаций за 15-летний период). Вопро-

сы практической педиатрии. 2022;17(2):126–135.

DOI: 10.20953/ 1817-7646-2022-2-126-135.

Мультидисциплинарные проблемы ожирения у детей.

Новикова В.П., Гурова М.М., ред. СПб.: СпецЛит; 2018.

Никитина И.Л. Ожирение у детей и подростков: про-

блема, пути решения. Обзор российских и междуна-

родных рекомендаций. Лечащий врач. 2018;(1):31–34.

Алиева Н.А. Особенности эндокринного статуса де-

вушек-подростков с ожирением различного генеза.

Вестник Волгоградского государственного медицин-

ского университета. 2007;1(21):26–29.

Firsova L.A., Shogiradze L.D., Evdokimova N.V. et al.

Нormonal and cytokine status in adolescent girls with

obesity. University Therapeutic Journal. 2022;4(S):137.

Голубев Н.А., Огрызко Е.В., Шелепова Е.А., За-

левская О.В. Заболеваемость детей болезнями

эндокринной системы, расстройствами питания

и нарушениями обмена веществ в рамках нацио-

нального проекта «Здравоохранения» Российской

Федерации. Современные проблемы здравоохране-

ния и медицинской статистики. 2019;(3):358–371.

DOI: 10.24411/2312-2935-2019-10072.

Урманова Ю.М., Азимова Ш.Ш., Рихсиева Н.Т. Ча-

стота и структура заболеваний щитовидной желе-

зы у детей и подростков по данным обращаемости.

Mìžnarodnij endokrinologìčnij žurnal. 2018;14(2):163–167.

DOI: 10.22141/2224-0721.14.2.2018.130562.

Огрызко Е.В., Шелепова Е.А., Кузнецова В.П. Динамика

заболеваемости щитовидной железы среди детей в воз-

расте 0–17 лет в Российской Федерации. Современные

проблемы здравоохранения и медицинской статистики.

;(3):341–356. DOI: 10.24411/2312-2935-2020-00076.

Sanabria A., Kowalski L.P., Shah J.P. et al. Growing incidence

of thyroid carcinoma in recent years: Factors underlying

overdiagnosis. Head Neck. 2018;40(4):855–866.

DOI: 10.1002/hed.25029.

Джумагазиев А.А., Безрукова Д.А., Шилина Н.А.,

Отто Н.Ю., Сосиновская Е.В., Филипчук А.В. Гене-

тические и эпигенетические факторы риска разви-

тия простого ожирения у детей: обзор литературы.

Педиа трическая фармакология. 2024;21(6):510–515.

DOI: 10.15690/pf.v21i6.2828.

Киселева А.В., Мешков А.Н., Ершова А.И. и др. Гене-

тика ожирения: современное состояние проблемы.

Профилактическая медицина. 2021;24(12):89–96.

DOI: 10.17116/profmed20212412189.

Ковтун О.П., Устюжанина М.А. Молекулярно-генети-

ческие основы формирования ожирения и связанных

с ним заболеваний у детей. Медицинская наука и об-

разование Урала. 2018;19(1):48–54.

Mahmoud R., Kimonis V., Butler M.G. Genetics of

obe sity in humans: a clinical review. Int J Mol Sci.

;23(19):11005. DOI: 10.3390/ijms231911005.

Battram T., Yousefi P., Crawford G. et al. The

EWAS Catalog: a database of epigenome-wide association

studies. Wellcome Open Res. 2022;7:41.

DOI: 10.12688/wellcomeopenres.17598.2.

Евдокимова Н.В., Новикова В.П., Нахимов Т.А. идр. Роль

полиморфизмов гена (AGT: с. 174C>T и AGT: с. 235T>С)

у детей с ожирением и кардиометаболи ческими

нарушениями. Медицинский совет. 2024;18(19):

–124. DOI: 10.21518/ms2024-387.

Евдокимова Н.В., Шогирадзе Л.Д., Похлебки-

на А.А. и др. Генетические детерминанты ожире-

ния у девочек-подростков. Российский вестник

перинатологии и педиатрии. 2024:69(2):65–71.

DOI: 10.21508/1027-4065-2024-69-2-65-71.

Persani L., Rodien P., Moran C., Visser W.E., Groeneweg

S., Peeters R., Refetoff S., Gurnell M.,

Beck-Peccoz P., Chatterjee K. 2024 European Thyroid

Association Guidelines on diagnosis and management

of genetic disorders of thyroid hormone transport, metabolism

and action. Eur Thyroid J. 2024;13(4):e240125.

DOI: 10.1530/ETJ-24-0125.

Rosalie B.T.M. Sterenborg, Inga Steinbrenner, Yong Li

et.al. Multi-trait analysis characterizes the genetics of

thyroid function and identifi es causal associations with

clinical implications. Nat Commun. 2024;15(1):888.

DOI: 10.1038/s41467-024-44701-9.

Vargas-Uricoechea H. Molecular Mechanisms in Autoimmune

Thyroid Disease. Cells. 2023;12(6):918.

DOI: 10.3390/cells12060918.

Амельянович М.Д., Моссэ И.Б. Молекулярно-гене-

тические маркеры риска развития эндокринной

патологии. Молекулярная и прикладная генетика.

;27:97–107. EDN: CIMAFT.

Кучер А.Н. Ген FTO и болезни: значимость генетиче-

ского полиморфизма, эпигенетических модификаций

и средовых факторов. Генетика. 2020;56(9):985–1005.

DOI: 10.31857/S0016675820090131.

Ji F.H., Fu X.H., Li G.Q., He Q., Qiu X.G. FTO Prevents

Thyroid Cancer Progression by SLC7A11

m6A Methy lation in a Ferroptosis-Dependent Manner.

Front Endocrinol (Lausanne). 2022;13:857765.

DOI: 10.3389/fendo.2022.857765.

Фатеева А.А., Мартиросян Н.С., Петунина Н.А. Им-

муногенетические особенности патологии щито-

видной железы при сочетании с метаболическим

синдромом. Медицинский совет. 2018;(4):116–119.

DOI: 10.21518/2079-701X-2018-4-116-119.

Deng M., Deng Y., Tang Z., Nie W., Lu Y., Wang X.,

WangZ., Kong Y. The Mechanism of Ranunculus ternatus

Thunb. against Esophageal Squamous Cell Carcinoma

Based on Network Pharmacology and Experimental

Verifi cation. Comb Chem High Throughput Screen. 2025.

DOI: 10.2174/0113862073376779250410054456.

Zakharova S.M., Savelieva L.V., Fadeeva M.I. Ожирение

и гипотиреоз. Ожирение и метаболизм. 2013;10(2):54–

DOI: 10.14341/2071-8713-4826.

Магомедова И.М., Камалов К.Г., Атаев М.Г., Арслан-

бекова А.Ч. Гипотиреоз и его роль в развитии нарушений углеводного и жирового обмена (обзор лите-

ратуры). Экологическая медицина. 2019:2(1):9–15.

DOI: 10.34662/EM.2019.2.1.9-15.

Fontenelle L.C., Feitosa M.M., Severo J.S., FreitasT.E.,

Morais J.B., Torres-Leal F.L., Henriques G.S., do

Nascimento Marreiro D. Thyroid function in human

obesity: underlying mechanisms. Horm Metab Res.

;48(12):787–794. DOI: 10.1055/s-0042-121421.

Grandone A., Santoro N., Coppola F., Calabrò P., Perrone

L., Del Giudice E.M. Thyroid function derangement

and childhood obesity: an Italian experience. BMC Endocr

Disord. 2010;10:8. DOI: 10.1186/1472-6823-10-8.

Гурина О.П., Дементьева Е.А., Блинов А.Е., Варла-

моваО.Н. Тиреоидный статус у детей, страдающих

ожирением. В сб.: VIII апрельские чтения памяти про-

фессора М.В. Пиккель. Материалы Межрегиональной

научно-практической конференции, посвященной па-

мяти профессора Пиккель М.В. 2020:40–43.

Biondi B. Subclinical hypothyroidism in patients with obesity

and metabolic syndrome: a narrative review. Nutrients.

;16(1):87. DOI: 10.3390/nu16010087.

Cheserek M.J., Wu G., Shen L., Shi Y. and Le G. Evaluation

of the relationship between subclinical hypothyroidism

and metabolic syndrome components among workers.

Int J Occup Med Environ Health. 2014;27:175–187.

DOI: 10.2478/s13382-014-0240-5.

Kota S.K., Meher L.K., Krishna S., Modi K. Hypothyroidism

in metabolic syndrome. Indian J Endocrinol

Metab. 2012;16(Suppl 2):332–333.

DOI: 10.4103/2230-8210.104079.

Feng X., Jiang Y., Meltzer P., Yen P.M. Thyroid hormone

regulation of hepatic genes in vivo detected

by complementary DNA microar ray. Mol Endocrinol.

;14(7):947–955. DOI: 10.1210/mend.14.7.0470.

Смирнов В.В., Ушаков А.И. Своевременная диагности-

ка и лечение гипотиреоза— основа здорового психи-

ческого и физического развития детей. Лечащий врач.

;1:10–16. DOI: 10.26295/OS.2019.77.67.002.

Shvarts V. Adipose tissue infl ammation. Part 1. Morphological

and functional manifestations. Probl Endokrinol

(Mosk). 2009;55(4):44–49. DOI: 10.14341/

probl200955444-49.

Sánchez B.T., Godoy S.J., García B.H., Barja Y.S.

Niveles de hormonas tiroideas en niños obesos [Thyroid

function in obese children]. Rev Chil Pediatr.

;85(3):288–297. (In Spanish). DOI: 10.4067/S0370-

Krause A.J., Cines B., Pogrebniak E., Sherafat-Kazemzadeh

R., Demidowich A.P., Galescu O.A., Brady S.M.,

Reynolds J.C., Hubbard V.S., Yanovski J.A. Associations

between adiposity and indicators of thyroid status in children

and adolescents. Pediatr Obes. 2016;11(6):551–558.

DOI: 10.1111/ijpo.12112.

Хавкин А.И., Колосова А.Д., Новикова В.П. Биологи-

ческая роль и клиническое значение лептина в педи-

атрии. Вопросы практической педиатрии. 2020;15(4):

–74. DOI: 10.20953/1817-7646-2020-4-69-74.

Dornbush S., Aeddula N.R. Physiology, Leptin. 2023

Apr 10. In: StatPearls [Internet]. Treasure Island (FL):

StatPearls Publishing; 2025 Jan.

Sucharda P. Obesity and thyroid gland. Cas Lek Cesk.

;161(5):194–197.

Pena-Leon V., Perez-Lois R., Villalon M., Prida E., Muñoz-

Moreno D., Fernø J., Quiñones M., Al-Massadi O., Seoane

L.M. Novel mechanisms involved in leptin sensitization

in obesity. Biochem Pharmacol. 2024;223:116129.

DOI: 10.1016/j.bcp.2024.116129.

Fatahi S., Fotros D., Sohouli M.H., Vahidshahi K., RohaniP.,

Guimarães N.S. Meal replacements on obesity and leptin: a

systematic review and meta-analysis. Rev Endocr Metab Disord.

;26(1):55–80. DOI: 10.1007/s11154-024-09918-5.

Сметник В.П. Половые гормоны и жировая ткань.

Ожирение и метаболизм. 2007;3:17–22.

Рязанцева Е.М. Лептин и репродуктивная система

женщин. Журнал акушерства и женских болезней.

;61(5):96–103. DOI: 10.17816/JOWD61596-103.

Soydan L., Eren Ozturk H., Onal Z.E., Nuhoglu C. Associations

of thyroid volume and function with childhood

obesity. Acta Endocrinol (Buchar). 2019;5(1):123–128.

DOI: 10.4183/aeb.2019.123.

Кишечная микробиота как регулятор работы ор-

ганов и систем человека. В.П. Новикова, М.М. Гу-

рова, А.И. Хавкин, ред. М.: ГЭОТАР-Медиа; 2024.

DOI: 10.33029/9704-8174-5-I.

Cani P.D., Van Hul M. Gut microbiota in overweight

and obesity: crosstalk with adipose tissue. Nat

Rev Gastroenterol Hepatol. 2024;21(3):164–183.

DOI: 10.1038/s41575-023-00867-z.

Angelini G., Russo S., Mingrone G. Incretin hormones,

obesity and gut microbiota. Peptides. 2024;178:171216.

DOI: 10.1016/j.peptides.2024.171216.

Azari H., George M., Albracht-Schulte K. Gut MicrobiotamicroRNA

interactions and obesity pathophysiology: a

systematic review of integrated studies. Int J Mol Sci.

;25(23):12836. DOI: 10.3390/ijms252312836.

Евдокимова Н.В., Похлебкина А.А., Петренко Ю.В.

и др. Особенности микробиоты кишечника у под-

ростков с ожирением. Актуальные проблемы абдоми-

нальной патологии у детей. Материалы Юбилейного

XXX конгресса детских гастроэнтерологов России

и стран СНГ. Москва, 14–16 марта 2023 года. М.:

Медпрактика-М; 2023: 166–168.

Евдокимова Н.В., Шогирадзе Л.Д., Похлебкина А.А.

и др. Микробиота тонкой кишки у девочек-подрост-

ков, страдающих ожирением. Экспериментальная и

клиническая гастроэнтерология. 2023;215(7):34–41.

DOI: 10.31146/1682-8658-ecg-215-7-34-41.

Stramazzo I., Capriello S., Filardo S., Centanni M., Virili

C. Microbiota and thyroid disease: an updated systematic

review. Adv Exp Med Biol. 2023;1370:125–144.

DOI: 10.1007/5584_2023_770.

Legakis I., Chrousos G.P., Chatzipanagiotou S. Thyroid

diseases and intestinal microbiome. Horm Metab Res.

;55(12):813–818. DOI: 10.1055/a-2190-3847.

Jiang W., Lu G., Gao D., Lv Z., Li D. The relationships between

the gut microbiota and its metabolites with thyroid

diseases. Front Endocrinol (Lausanne). 2022;13:943408.

DOI: 10.3389/fendo.2022.943408.

Земскова Е.А., Струков Е.Л., Мельникова И.Ю., Нови-

кова В.П., Антонов П.В. Избыточный рост Eubacterium

lentum в пристеночной кишечной микрофлоре как

фактор риска развития тиреоидита у детей. Вестник

Северо-Западного государственного медицинского

университета им. И.И. Мечникова. 2012;4(4):73–77.

Tabasi M., Eybpoosh S., Heravi F.S., Siadat S.D., Mousavian

G., Elyasinia F., Soroush A., Bouzari S. Gut microbiota

and serum biomarker analyses in obese patients diagnosed

with diabetes and hypothyroid disorder. Metabolic

Syndrome and Related Disorders. 2021;19(3):144–151.

DOI: 10.1089/met.2020.0119.

Wang Y., Dong X., Fu C., Su M., Jiang F., Xu D., Li R.,

QianJ., Wang N., Chen Y., Jiang Q. Thyroid stimulating

hormone (tsh) is associated with general and abdominal

obesity: a cohort study in school-aged girls during puberty

in East China. Front Endocrinol (Lausanne). 2020;11:620.

DOI: 10.3389/fendo.2020.00620.

Benvenga S., Di Bari F., Granese R., Borrielli I., GiorgianniG.,

Grasso L., Le Donne M., Vita R., Antonelli A. Circulating

thyrotropin is upregulated by estradiol. J Clin Transl Endocrinol.

;11:11–17. DOI: 10.1016/j.jcte.2018.02.002.

Терещенко И.В., Кривощекова О.Ю. Состояние ги-

поталамо-гипофизарно-тиреоидной системы у

больных пубертатно-юношеским диспитуитариз-

мом. Проблемы эндокринологии. 2000;46(5):18–21.

DOI: 10.14341/probl11871.

Nader N.S., Bahn R.S., Johnson M.D., Weaver A.L., SinghR.,

Kumar S. Relationships between thyroid function and lipid

status or insulin resistance in a pediatric population. Thyroid.

;20(12):1333–1339. DOI: 10.1089/thy.2010.0180.

Мустафаева И.Р. Особенности изменения гор-

монального фона у девочек-подростков с ожи-

рением в период полового созревания. Россий-

ский вестник акушера-гинеколога. 2023;23(4):5–8.

DOI: 10.17116/rosakush2023230415.